Hyaluronidase has become an essential tool in cosmetic dermatology as an eraser of unwanted hyaluronic acid (HA) filler. The purpose of this Editorial is to update the reader on the evidence supporting the use of hyaluronidase in (1) the emergency treatment of vascular occlusion from accidental injection of HA into a blood vessel and (2) the more common case of removing small amounts of HA that are simply unwanted, which is the purpose of the study published by Alam and colleagues1 in this issue of JAMA Dermatology.
Jones DH. Update on Emergency and Nonemergency Use of Hyaluronidase in Aesthetic Dermatology. JAMA Dermatol. 2018;154(7):763–764. doi:10.1001/jamadermatol.2018.0516
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: